{"created_at": "2022-01-14T02:44:31.000Z", "text": "Join FREE today for a 10-day trial, utilizing our stock &amp; option alerts, advisor experience, technology, market analysis, and synergetic community of over 200,000.\rhttps://t.co/rb5embL5oX\r\n$abbv https://t.co/rAi1mCTkmQ", "id": "1481819486051188737", "author_id": "1481564704174592000"}
{"created_at": "2022-01-14T18:15:30.000Z", "text": "$ABBV U.S. FDA approves rinvoq\u00ae (upadacitinib) to treat adults and children 12 years and older with refractory, moderate to severe atopic dermatitis", "id": "1482053778408935426", "author_id": "1058344962285289472"}
{"text": "RT @DeItaone: U.S. FDA APPROVES RINVOQ\u00ae (UPADACITINIB) TO TREAT ADULTS AND CHILDREN 12 YEARS AND OLDER WITH REFRACTORY, MODERATE TO SEVERE\u2026", "created_at": "2022-01-14T20:10:49.000Z", "id": "1482082799066791938", "author_id": "1099102523405811712"}
